ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR-59.8%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
-59.8%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202521.18%
202468.57%
2023-10.79%
2022324.81%
20210.00%